FindTrial
Sign In

Basis of theory of 'Exterior-Interior Correlation Between the Lung and Large Intestine' to explore the prevention and treatment strategies of Traditional Chinese Medicine in patients with lung function decreased of chronic pulmonary diseases complicated with functional constipation

A randomized controlled trial of traditional Chinese medicine intervention measures in patients with lung function decreased of chronic pulmonary diseases complicated with functional constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058186
Enrollment
Unknown
Registered
2022-04-01
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pulmonary diseases complicated with functional constipation

Interventions

Traditional Chinese medicine oral group (Group A):General treatment +Oral traditional Chinese medicine
Traditional Chinese medicine external treatment group (Group B):General treatment +Acupoint Application + intradermal needle
Control group (Group C):General treatment +oral Mosapride Citrate tablets

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Seciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients who conform to the diagnostic criteria of chronic pulmonary disease and functional constipation; 2. The pulmonary disease is in a stable stage, and lung function test showed ventilation or diffusion function decreased; 3. The syndromes is Lung qi deficiency,Intestinal dryness; 4. The age ranged from 40 to 80 years old; 5. The patients do not participating in other clinical studies within 1 month before enrollment; 6. The patients should accept the treatment plan and sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. The patients combined with organic gastrointestinal or anorectal diseases, and the patients who accept abdominal surgery recently; 2. The patients combined with malignant tumors or other primary diseases, such as severe cardiovascular, cerebrovascular, renal, liver, hematological dease and so on; 3. The patients combined with severe constipation and alarm signs (according to "Guideline for primary care of chronic constipation(2019)"made by Chinese Medical Association), the patients who has not exclude organic lesions and without specialist examination,the patients who has complications (such as intestinal obstruction, intestinal perforation, peritonitis and so on ); 4. The patients who are allergic, taboo or intolerant to the intervention measures in this project; 5. Pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
The quantitative scores of symptom;Quality of life assessment;lung function indexes;Safety indicators;—

Countries

China

Contacts

Public ContactWu Wei

Wangjing Hospital, China Academy of Chinese Medical Sciences

13651285699@163.com+86 13651285699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026